MIH
ABBV icon

Meitav Investment House’s AbbVie ABBV Stock Holding History

Meitav Investment House’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,553
Closed -$631K – 218
2024
Q4 		$631K Sell
3,553
-88
-2% -$16.2K 0.01% 151
2024
Q3 		$711K Hold
3,641
– – 0.01% 155
2024
Q2 		$616K Sell
3,641
-100
-3% -$16.6K 0.01% 158
2024
Q1 		$681K Buy
3,741
+134
+4% +$23.1K 0.01% 156
2023
Q4 		$558K Hold
3,607
– – 0.01% 237
2023
Q3 		$549K Hold
3,607
– – 0.01% 249
2023
Q2 		$481K Hold
3,607
– – 0.01% 278
2023
Q1 		$569K Sell
3,607
-2,518
-41% -$385K 0.01% 277
2022
Q4 		$993K Hold
6,125
– – 0.02% 238
2022
Q3 		$853K Buy
6,125
+24
+0.4% +$3.44K 0.02% 246
2022
Q2 		$934K Sell
6,101
-3,640
-37% -$556K 0.02% 237
2022
Q1 		$1.58M Buy
+9,741
New +$1.41M 0.02% 235
2020
Q3 		– Sell
-150,000
Closed -$14.7M – 395
2020
Q2 		$14.7M Buy
+150,000
New +$13.2M 0.88% 50
2018
Q4 		– Sell
-6,241
Closed -$590K – 337
2018
Q3 		$590K Sell
6,241
-2,242
-26% -$213K 0.03% 287
2018
Q2 		$786K Sell
8,483
-851
-9% -$83.1K 0.04% 265
2018
Q1 		$884K Buy
+9,334
New +$1.03M 0.05% 196

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Meitav Investment House's ABBV Position: Q1 2025 in Review

Meitav Investment House sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 3,553 shares — an estimated $631K sold.

Meitav Investment House first reported a position in ABBV in Q1 2018 and held it in 16 quarters. The position peaked at $14.7M in Q2 2020. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Meitav Investment House reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Meitav Investment House sold 3,553 AbbVie shares in Q1 2025, an estimated $631K.
  • Meitav Investment House first reported a position in AbbVie in Q1 2018 and held it in 16 quarters.
  • Meitav Investment House's AbbVie position peaked at $14.7M in Q2 2020.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Meitav Investment House's 13F filing for Q1 2025, filed 12 May 2025.